TSMC reported Q2 revenue of NT$1.27 trillion ($39.63 billion), marking a 36% year-over-year increase. These results slightly exceeded analyst expectations of NT$1.264 trillion, confirming that the company beat market estimates. Following this performance, investor focus is now shifting toward upcoming earnings reports from major firms including UnitedHealth, Abbott Laboratories, and GE Aerospace.
